Indications and Purposes
| 1 Indications And Usage Granix Is Indicated To Reduce The Duration Of Severe Neutropenia In Adult And Pediatric Patients 1 Month And Older With Non-Myeloid Malignancies Receiving Myelosuppressive Anticancer Drugs Associated With A Clinically Significant Incidence Of Febrile Neutropenia. Granix (Tbo-Filgrastim) Is A Leukocyte Growth Factor Indicated In Adult And Pediatric Patients 1 Month And Older For Reduction In The Duration Of Severe Neutropenia In Patients With Non-Myeloid Malignancies Receiving Myelosuppressive Anti-Cancer Drugs Associated With A Clinically Significant Incidence Of Febrile Neutropenia. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Filgrastim |